Antitumour action of planar, organometallic rhodium(I) complexes.
D000818:Animals; D000970:Antineoplastic Agents / Q000008:administration & dosage / Q000627:therapeutic use*; D002277:Carcinoma / Q000188:drug therapy; D002286:Carcinoma, Ehrlich Tumor / Q000188:drug therapy; D002460:Cell Line; D004273:DNA, Neoplasm / Q000378:metabolism; D004305:Dose-Response Relationship, Drug; D007274:Injections, Intraperitoneal; D007930:Leucine / Q000378:metabolism; D007939:Leukemia L1210 / Q000188:drug therapy; D051379:Mice; D009062:Mouth Neoplasms / Q000188:drug therapy; D009363:Neoplasm Proteins / Q000378:metabolism; D009942:Organometallic Compounds / Q000627:therapeutic use*; D012334:RNA, Neoplasm / Q000378:metabolism; D012238:Rhodium / Q000627:therapeutic use*; D012510:Sarcoma 180 / Q000188:drug therapy
D000970:Antineoplastic Agents; D004273:DNA, Neoplasm; D009363:Neoplasm Proteins; D009942:Organometallic Compounds; D012334:RNA, Neoplasm; D012238:Rhodium; D007930:Leucine